# Injectable Buprenorphine in Prison: A Preference Trial

> **NCT06880718** · PHASE4 · RECRUITING · sponsor: **Lifespan** · enrollment: 60 (estimated)

## Conditions studied

- Opioid Use Disorder
- Incarceration
- Medications for Opioid Use Disorder
- Buprenorphine

## Interventions

- **DRUG:** Brixadi (Injectable Buprenorphine)
- **DRUG:** Sublocade

## Key facts

- **NCT ID:** NCT06880718
- **Lead sponsor:** Lifespan
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-18
- **Primary completion:** 2027-01
- **Final completion:** 2027-06
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-05-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06880718

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06880718, "Injectable Buprenorphine in Prison: A Preference Trial". Retrieved via AI Analytics 2026-09-01 from https://api.ai-analytics.org/clinical/NCT06880718. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*